Quest Diagnostics (DGX): Is Rapid Test Growth Translating Into Better Customer Economics?
Quest Diagnostics Incorporated (NYSE:DGX) is processing substantially more laboratory work as hospitals and dialysis providers expand their testing relationships. Organic requisitions grew 11.9% year over year in the first half and 13.0% in the second quarter. Yet lower revenue per requisition and a narrower operating margin make the investment question more demanding: how much additional […]
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo